Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
Join a forward-thinking company dedicated to enhancing lives through innovative technology. As a Controls Technician, you'll lead the installation and start-up of cutting-edge equipment, ensuring efficiency and reliability in a dynamic environment. Your expertise in troubleshooting and programming will be crucial in maintaining high standards of quality and safety. This role offers a unique opportunity to contribute to impactful projects while working alongside a passionate team. If you're ready to take on challenges and make a difference in the medical device industry, this position is perfect for you.
Insulet started in 2000 with an idea and a mission to enable our customers to enjoy simplicity, freedom, and healthier lives through our Omnipod product platform. Over the last two decades, we have improved the lives of hundreds of thousands of patients using innovative, wearable, waterproof, and lifestyle-friendly technology.
We are seeking highly motivated, performance-driven individuals to join our expanding team. We hire exceptional people guided by shared values who exceed customer expectations. Our continued success depends on it!
Controls Technician - Malaysia
Engineering
The candidate will lead the installation and start-up of new equipment, improve existing equipment, and support continuous improvement initiatives. The Controls Technician should be able to troubleshoot machines using programming tools. The candidate must be self-driven, quick to learn, and capable of working in a dynamic environment with multiple projects.
The successful candidate will possess strong structured problem-solving skills for complex component and machine interactions and be comfortable working hands-on with automation machinery.
Insulet Corporation (NASDAQ: PODD) is dedicated to making life easier for people with diabetes. Through its OmniPod Insulin Management System, Insulet aims to expand insulin pump therapy among insulin-dependent individuals. The company also partners globally to adapt its technology for delivering subcutaneous drugs across various therapeutic areas.